Procter & Gamble (PG)
(Delayed Data from NYSE)
$165.76 USD
+0.68 (0.41%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $166.27 +0.51 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.76 USD
+0.68 (0.41%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $166.27 +0.51 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $148.74, representing a +1.5% change from its previous close.
Is FlexShares Quality Dividend Defensive ETF (QDEF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QDEF
The Zacks Analyst Blog Highlights Molson Coors Beverage, The Procter & Gamble, The Coca-Cola and The Kraft Heinz
by Zacks Equity Research
Molson Coors Beverage, The Procter & Gamble, The Coca-Cola and The Kraft Heinz are part of the Zacks top Analyst Blog.
Procter & Gamble (PG) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $146.06, marking a +0.08% move from the previous day.
Craft a Solid Portfolio for 2024 With 4 Consumer Staple Stocks
by Vrishali Bagree
Moderating inflation, operational efficiency and pricing power present great opportunities for consumer staple players like Molson Coors (TAP), Procter & Gamble (PG), Coca-Cola (KO) and Kraft Heinz (KHC).
The Zacks Analyst Blog Highlights Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours
by Zacks Equity Research
Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours are part of the Zacks top Analyst Blog.
3 Standout Dow Stocks That Could Soar in 2024
by Harsh Sadavartia
Based on healthy fundamentals, we have shortlisted three Dow stocks - PG, KO and IBM - that are likely to perform better in 2024.
Procter & Gamble (PG) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $146.17 in the latest trading session, marking no change from the prior day.
4 ETF Areas & Stocks to Win on Upbeat November Retail Sales
by Sanghamitra Saha
Retail Sales in the United States increased 4.1% year-on-year in November 2023, marking the strongest annual growth since February, following a downwardly revised 2.2% gain in October.
Is FlexShares Quality Dividend ETF (QDF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QDF
Procter & Gamble (PG) Laps the Stock Market: Here's Why
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $146.17, representing a +1.54% change from its previous close.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Here's Why Procter & Gamble (PG) Gained But Lagged the Market Today
by Zacks Equity Research
In the most recent trading session, Procter & Gamble (PG) closed at $145.94, indicating a +0.08% shift from the previous trading day.
Top 5 Consumer Staples Stocks for a Stable Portfolio in 2024
by Nalak Das
We have narrowed our search to five consumer staples stocks with strong growth potential for 2024. These are: CELH, PG, KHC, TAP, ELF.
Here's What Keeps Procter & Gamble (PG) on Growth Track
by Zacks Equity Research
Procter & Gamble (PG) looks well-placed for growth on strong demand, pricing actions, favorable mix and focus on productivity and cost-saving plans.
Procter & Gamble (PG) Stock Moves -0.07%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $146.65 in the latest trading session, marking a -0.07% move from the prior day.
4 Stocks With Impressive Interest Coverage Ratio to Snap Up
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. EG, MOD, STRL and PG are sound enough to meet financial obligations.
Is Laird Superfood (LSF) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Laird Superfood, Inc. (LSF) and Procter & Gamble (PG) have performed compared to their sector so far this year.
Brokers Suggest Investing in P&G (PG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble (PG) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Procter & Gamble (PG) reachead $153.52 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.
Procter & Gamble (PG) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the most recent trading session, Procter & Gamble (PG) closed at $151.38, indicating a +0.24% shift from the previous trading day.
The Zacks Analyst Blog Highlights Intel, The Procter & Gamble, 3M, salesforce.com and Microsoft
by Zacks Equity Research
Intel, The Procter & Gamble, 3M, salesforce.com and Microsoft are part of the Zacks top Analyst Blog .
5 Top Blue-Chip Stocks to Gain From Recent Market Rally
by Nalak Das
Defying a tepid Dow, we have narrowed our search to five blue-chip (components of Dow) stocks are: MSFT, MMM, CRM, INTC, PG.
Top 5 U.S. Giants for 2024 That Have Failed to Deliver in 2023
by Nalak Das
We have narrowed our search to five U.S. corporate giants that have failed to deliver in 2023. These are: PEP, PG, MMM, XOM, GILD.
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals
by Zacks Equity Research
Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.